William O. Boggan

2.1k total citations
64 papers, 1.7k citations indexed

About

William O. Boggan is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, William O. Boggan has authored 64 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cellular and Molecular Neuroscience, 20 papers in Molecular Biology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in William O. Boggan's work include Neuroscience and Neuropharmacology Research (22 papers), Neurotransmitter Receptor Influence on Behavior (21 papers) and Prenatal Substance Exposure Effects (9 papers). William O. Boggan is often cited by papers focused on Neuroscience and Neuropharmacology Research (22 papers), Neurotransmitter Receptor Influence on Behavior (21 papers) and Prenatal Substance Exposure Effects (9 papers). William O. Boggan collaborates with scholars based in United States. William O. Boggan's co-authors include Kurt Schlesinger, Neil Buckholtz, Daniel X. Freedman, Lawrence D. Middaugh, Boris Tabakoff, Lewis S. Seiden, J. B. Appel, John W. Zemp, Sebastian P. Grossman and Darryl B. Neill and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Genetics.

In The Last Decade

William O. Boggan

64 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William O. Boggan United States 25 960 561 260 174 162 64 1.7k
Zehava Gottesfeld United States 24 1.1k 1.1× 542 1.0× 239 0.9× 122 0.7× 259 1.6× 70 1.9k
Göran Wahlström Sweden 25 1.1k 1.1× 521 0.9× 118 0.5× 60 0.3× 260 1.6× 108 1.9k
Zoltan Annau United States 23 886 0.9× 490 0.9× 159 0.6× 125 0.7× 528 3.3× 63 2.2k
Charles O. Rutledge United States 25 1.4k 1.4× 963 1.7× 73 0.3× 117 0.7× 140 0.9× 71 2.2k
Alexander Jakubovič Canada 20 1.1k 1.1× 629 1.1× 126 0.5× 77 0.4× 308 1.9× 59 1.6k
Manfred Karobath Austria 33 2.0k 2.1× 1.4k 2.4× 165 0.6× 127 0.7× 249 1.5× 74 2.7k
A. Groppetti Italy 26 1.4k 1.4× 678 1.2× 72 0.3× 100 0.6× 149 0.9× 54 2.0k
R.P. Maickel United States 22 780 0.8× 468 0.8× 60 0.2× 131 0.8× 136 0.8× 78 1.8k
S. Algeri Italy 20 999 1.0× 541 1.0× 76 0.3× 62 0.4× 165 1.0× 58 1.8k
Christine L. Melchior United States 22 994 1.0× 511 0.9× 62 0.2× 77 0.4× 244 1.5× 40 1.6k

Countries citing papers authored by William O. Boggan

Since Specialization
Citations

This map shows the geographic impact of William O. Boggan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William O. Boggan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William O. Boggan more than expected).

Fields of papers citing papers by William O. Boggan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William O. Boggan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William O. Boggan. The network helps show where William O. Boggan may publish in the future.

Co-authorship network of co-authors of William O. Boggan

This figure shows the co-authorship network connecting the top 25 collaborators of William O. Boggan. A scholar is included among the top collaborators of William O. Boggan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William O. Boggan. William O. Boggan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Weidong, et al.. (1997). The interactive effects of cocaine/gender on immune function in mice. An observation of in vivo acute cocaine exposure. International Journal of Immunopharmacology. 19(6). 333–340. 11 indexed citations
2.
Middaugh, Lawrence D., William O. Boggan, Sarah A. Bingel, Kennerly S. Patrick, & Weidong Xu. (1996). A murine model of prenatal cocaine exposure: Effects on the mother and the fetus. Pharmacology Biochemistry and Behavior. 55(4). 565–574. 16 indexed citations
3.
Boggan, William O., et al.. (1996). Effects of prenatal ethanol exposure on dopamine systems in C57BL/6J mice. Neurotoxicology and Teratology. 18(1). 41–48. 18 indexed citations
4.
Middaugh, Lawrence D. & William O. Boggan. (1995). Perinatal Maternal Ethanol Effects on Pregnant Mice and on Offspring Viability and Growth: Influences of Exposure Time and Weaning Diet. Alcoholism Clinical and Experimental Research. 19(5). 1351–1358. 22 indexed citations
5.
Boggan, William O., et al.. (1994). 重水素化内標準物質とガスクロマトグラフィー‐質量分析法によるマウスの血しょうコカインとエチルコカイン(コカエチレン)の定量. Journal of Chromatography B. 656(2). 335–341. 2 indexed citations
6.
Patrick, Kennerly S., et al.. (1993). Gas chromatographic—mass spectrometric determination of plasma and brain cocaine in mice. Journal of Chromatography B Biomedical Sciences and Applications. 621(1). 89–94. 15 indexed citations
7.
Becker, Howard C., Robert L. Hale, William O. Boggan, & Carrie L. Randall. (1993). Effects of Prenatal Ethanol Exposure on Later Sensitivity to the Low‐Dose Stimulant Actions of Ethanol in Mouse Offspring: Possible Role of Catecholamines. Alcoholism Clinical and Experimental Research. 17(6). 1325–1336. 29 indexed citations
8.
Middaugh, Lawrence D., et al.. (1992). Gender differences in the effects of ethanol on C57BL/6 mice. Alcohol. 9(3). 257–260. 62 indexed citations
9.
Middaugh, Lawrence D. & William O. Boggan. (1991). Postnatal Growth Deficits in Prenatal Ethanol‐Exposed Mice: Characteristics and Critical Periods. Alcoholism Clinical and Experimental Research. 15(6). 919–926. 49 indexed citations
10.
Boggan, William O. & J.G. Ondo. (1989). Effect of central administration of phencyclidine on plasma concentrations of luteinizing hormone. Brain Research. 478(2). 382–384. 1 indexed citations
11.
Boggan, William O. & Lawrence D. Middaugh. (1989). Effect of central injection of phencyclidine on QNB accumulation and motor activity. European Journal of Pharmacology. 166(2). 123–129. 1 indexed citations
12.
Boggan, William O., et al.. (1982). Effect of phencyclidine on plasma corticosterone in mice. Life Sciences. 30(18). 1581–1586. 8 indexed citations
13.
Boggan, William O., Jerrold S. Meyer, L.D. Middaugh, & David L. Sparks. (1979). Ethanol, Calcium, and Naloxone in Mice. Alcoholism Clinical and Experimental Research. 3(2). 158–161. 7 indexed citations
14.
Joseph, James A., William O. Boggan, & D. A. Powell. (1979). Adrenal demedullation and peripheral 6-OHDA administration in the rabbit: Effects on body weight, general activity and cardiovascular responsivity. Pharmacology Biochemistry and Behavior. 10(6). 875–881. 1 indexed citations
15.
Boggan, William O., et al.. (1978). Effect of taurine on some pharmacological properties of ethanol. Pharmacology Biochemistry and Behavior. 9(4). 469–472. 33 indexed citations
16.
Buckholtz, Neil & William O. Boggan. (1977). Monoamine oxidase inhibition in brain and liver produced by β-carbolines: structure-activity relationships and substrate specificity. Biochemical Pharmacology. 26(21). 1991–1996. 156 indexed citations
17.
Miczek, Klaus A., Jack Altman, J. B. Appel, & William O. Boggan. (1975). Para-chlorophenylalanine, serotonin and killing behavior. Pharmacology Biochemistry and Behavior. 3(3). 355–361. 80 indexed citations
18.
Neill, Darryl B., William O. Boggan, & Sebastian P. Grossman. (1974). Impairment of avoidance performance by intrastriatal administration of 6-hydroxydopamine. Pharmacology Biochemistry and Behavior. 2(1). 97–103. 37 indexed citations
19.
Boggan, William O., Daniel X. Freedman, & J. B. Appel. (1973). p-Chlorophenylalanine-induced alterations in the behavioral effects of 5-hydroxytryptophan. Psychopharmacology. 33(4). 293–298. 16 indexed citations
20.
Schlesinger, Kurt, et al.. (1969). Modification of audiogenic and pentylenetetrazol seizures with gamma-aminobutyric acid, norepinephrine and serotonin. Psychopharmacology. 15(3). 226–231. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zehava Gottesfeld Breakdown of academic impact, for papers by Göran Wahlström Breakdown of academic impact, for papers by Zoltan Annau Breakdown of academic impact, for papers by Charles O. Rutledge Breakdown of academic impact, for papers by Alexander Jakubovič Breakdown of academic impact, for papers by Manfred Karobath Breakdown of academic impact, for papers by A. Groppetti Breakdown of academic impact, for papers by R.P. Maickel Breakdown of academic impact, for papers by S. Algeri Breakdown of academic impact, for papers by Christine L. Melchior
Rankless by CCL
2026